These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32866414)

  • 1. Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline.
    Doyle-Delgado K; Chamberlain JJ; Shubrook JH; Skolnik N; Trujillo J
    Ann Intern Med; 2020 Nov; 173(10):813-821. PubMed ID: 32866414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes.
    Chamberlain JJ; Herman WH; Leal S; Rhinehart AS; Shubrook JH; Skolnik N; Kalyani RR
    Ann Intern Med; 2017 Apr; 166(8):572-578. PubMed ID: 28288484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes.
    Chamberlain JJ; Doyle-Delgado K; Peterson L; Skolnik N
    Ann Intern Med; 2019 Sep; 171(6):415-420. PubMed ID: 31404925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Type 1 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes.
    Chamberlain JJ; Kalyani RR; Leal S; Rhinehart AS; Shubrook JH; Skolnik N; Herman WH
    Ann Intern Med; 2017 Oct; 167(7):493-498. PubMed ID: 28892816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.
    Qaseem A; Barry MJ; Humphrey LL; Forciea MA; ; Fitterman N; Horwitch C; Kansagara D; McLean RM; Wilt TJ
    Ann Intern Med; 2017 Feb; 166(4):279-290. PubMed ID: 28055075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes.
    Chamberlain JJ; Rhinehart AS; Shaefer CF; Neuman A
    Ann Intern Med; 2016 Apr; 164(8):542-52. PubMed ID: 26928912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians.
    Qaseem A; Humphrey LL; Sweet DE; Starkey M; Shekelle P;
    Ann Intern Med; 2012 Feb; 156(3):218-31. PubMed ID: 22312141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [American Diabetes Association's Annual Meeting: new data on insulin glargine: early combination promises more success].
    MMW Fortschr Med; 2005 Aug; 147(33-34):44-5. PubMed ID: 16138636
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018.
    Chamberlain JJ; Johnson EL; Leal S; Rhinehart AS; Shubrook JH; Peterson L
    Ann Intern Med; 2018 May; 168(9):640-650. PubMed ID: 29610837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020.
    Hirsch IB; Gaudiani LM
    JAMA; 2020 Jun; 323(23):2419-2420. PubMed ID: 32442246
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination therapy when metformin is not an option for type 2 diabetes.
    Goldman-Levine JD
    Ann Pharmacother; 2015 Jun; 49(6):688-99. PubMed ID: 25770115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow response to loss of glycemic control in type 2 diabetes mellitus.
    Brown JB; Nichols GA
    Am J Manag Care; 2003 Mar; 9(3):213-7. PubMed ID: 12643338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes.
    Ampudia-Blasco FJ; Benhamou PY; Charpentier G; Consoli A; Diamant M; Gallwitz B; Khunti K; Mathieu C; Ridderstråle M; Seufert J; Tack C; Vilsbøll T; Phan TM; Stoevelaar H
    Diabetes Technol Ther; 2015 Mar; 17(3):194-202. PubMed ID: 25347226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8. Pharmacologic Approaches to Glycemic Treatment:
    American Diabetes Association
    Diabetes Care; 2018 Jan; 41(Suppl 1):S73-S85. PubMed ID: 29222379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin useful in combination with exogenous insulin.
    Hanuschak LN
    Diabetes Care; 1996 Jun; 19(6):671-2. PubMed ID: 8725873
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
    Thrasher J
    Am J Cardiol; 2017 Jul; 120(1S):S4-S16. PubMed ID: 28606343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical treatment of type 2 diabetes. Recommendations for good practice].
    Diabetes Metab; 2007 Jan; 33(1 Pt 2):1S26-105. PubMed ID: 17499188
    [No Abstract]   [Full Text] [Related]  

  • 18. How long can insulin therapy be avoided in the patient with type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea?
    Bell DS; Ovalle F
    Endocr Pract; 2000; 6(4):293-5. PubMed ID: 11242605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating treatment algorithms for the management of patients with type 2 diabetes mellitus: a perspective on the definition of treatment success.
    Aguilar RB
    Clin Ther; 2011 Apr; 33(4):408-24. PubMed ID: 21635988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
    Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
    Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.